EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Advancing Precision Medicine for Hypertensive Nephropathy: A Novel Prognostic Model Incorporating Pathological Indicators

Yunlong Qin, Jin Zhao, Yan Xing, Zixian Yu, Panpan Liu, Yuwei Wang, Anjing Wang, Yueqing Hui, Wei Zhao, Mei Han, Meng Liu, Xiaoxuan Ning und 1 weitere

Kidney and Blood Pressure Research · 29.03.2025 · 50 (1) · 309-320

DOI: 10.1159/000545524 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kidney and Blood Pressure Research, online erschienen am 29.03.2025. Verfasst von Yunlong Qin und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Xijing Hospital, Fourth Military Medical University, Xi'an, China, 379925000@qq.com. Hauptthemen laut MEDLINE: Precision Medicine, Hypertension, Renal, Nephritis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

This study aimed to assess the long-term renal prognosis of patients with hypertensive nephropathy (HN) diagnosed through renal biopsy, utilizing the random survival forest (RSF) algorithm.

Methods

From December 2010 to December 2022, HN patients diagnosed by renal biopsy in Xijing Hospital were enrolled and randomly divided into training set and testing set at a ratio of 7∶3. The study’s composite endpoint was defined as a ≥50% decline in estimated glomerular filtration rate (eGFR), end-stage renal disease, or death. RSF and Cox regression were used to establish a renal prognosis prediction model based on the factors screened by the RSF algorithm. The Concordance index (C-index), integrated Brier score, net reclassification improvement (NRI), and integrated discrimination improvement (IDI) were used to evaluate discrimination, calibration, and risk classification, respectively.

Results

A total of 225 patients were included in this study, with 72 (32.0%) patients experiencing combined events after a median follow-up of 29.9 (16.6, 52.1) months. Six eligible variables (overall chronicity grade of renal pathology, eGFR, high-density lipoprotein cholesterol, hematocrit, monocyte, and stroke volume) were selected from clinical data and introduced into the RSF model. The RSF model had a higher C-index in both the training set (0.904 [95% CI: 0.842–0.938] vs. 0.831 [95% CI: 0.768–0.894], p < 0.001) and the testing set (0.893 [95% CI: 0.770–0.944] vs. 0.841 [95% CI: 0.751–0.931], p = 0.021) compared to the Cox model. NRI and IDI indicated that the RSF model outperformed the Cox model regarding risk classification.

Conclusion

In this study, the RSF algorithm was employed to identify the risk factors affecting the prognosis of HN patients, and a clinical prognostic RSF model was constructed to predict the adverse outcomes of HN patients based on renal pathology. Compared to the traditional Cox regression model, the RSF model offers superior performance and can provide valuable new insights for clinical diagnosis and treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Precision MedicineHypertension, RenalNephritisHumansPrognosisMaleFemaleMiddle AgedGlomerular Filtration RateAgedAdultAlgorithms

Stichwörter der Autor:innen

HypertensionHypertensive nephropathyHypertensive nephrosclerosisMachine learningPrognostic model

Autor:innen und Institutionen

  • Department of Nephrology, Xijing Hospital, Fourth Military Medical University, Xi'an, China, 379925000@qq.com.
  • Department of Nephrology, Bethune International Peace Hospital, Shijiazhuang, China, 379925000@qq.com.
  • Department of Nephrology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
  • The Outpatient Clinic, the 95026 Hospital of PLA, Foshan, China.
  • Department of Nephrology, Bethune International Peace Hospital, Shijiazhuang, China.
  • Department of Geriatrics, Xijing Hospital, Fourth Military Medical University, Xi'an, China.

Zitieren

APA

Qin, Y., Zhao, J., Xing, Y., Yu, Z., Liu, P., Wang, Y., Wang, A., Hui, Y., Zhao, W., Han, M., Liu, M., Ning, X., & Sun, S. (2025). Advancing Precision Medicine for Hypertensive Nephropathy: A Novel Prognostic Model Incorporating Pathological Indicators. Kidney and Blood Pressure Research, 50(1), 309-320. https://doi.org/10.1159/000545524

Vancouver

Qin Y, Zhao J, Xing Y, Yu Z, Liu P, Wang Y, et al. Advancing Precision Medicine for Hypertensive Nephropathy: A Novel Prognostic Model Incorporating Pathological Indicators. Kidney and Blood Pressure Research. 2025;50(1):309-320. doi:10.1159/000545524

BibTeX
@article{Qin2025,
  author = {Qin, Yunlong and Zhao, Jin and Xing, Yan and Yu, Zixian and Liu, Panpan and Wang, Yuwei and Wang, Anjing and Hui, Yueqing and Zhao, Wei and Han, Mei and Liu, Meng and Ning, Xiaoxuan and Sun, Shiren},
  title = {Advancing Precision Medicine for Hypertensive Nephropathy: A Novel Prognostic Model Incorporating Pathological Indicators},
  journal = {Kidney and Blood Pressure Research},
  year = {2025},
  volume = {50},
  number = {1},
  pages = {309--320},
  doi = {10.1159/000545524}
}
Kostenlos starten →